miR‑375‑3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor‑1&beta;

Chang,Kunpeng; Wei,Zhenxing; Cao,Hua

doi:10.3892/ol.2020.11941

October-2020 Volume 20 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October-2020 Volume 20 Issue 4

Full Size Image

Article Open Access

miR‑375‑3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor‑1β

Authors:
- Kunpeng Chang
- Zhenxing Wei
- Hua Cao
View Affiliations / Copyright

Affiliations: Department of Otolaryngology Head and Neck Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan 471000, P.R. China, Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China

Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 80
|
Published online on: August 3, 2020

https://doi.org/10.3892/ol.2020.11941
Expand metrics +

Abstract

Laryngeal squamous cell carcinoma (LSCC) is one of the most frequently diagnosed head and neck cancers worldwide. Increasing evidence suggests that microRNAs (miRNAs/miRs) regulate the progression of tumorigenesis and the malignant behaviors of cancer cells. The aim of this study was to investigate the function and underlying mechanism of miR‑375‑3p in LSCC. The expression of miR‑375‑3p in LSCC tissues and cells was detected using reverse transcription‑quantitative PCR. The effects of miR‑375‑3p on the malignant phenotype of LSCC cells was determined using the Cell Counting Kit‑8 assay and flow cytometry. The targets of miR‑375‑3p were predicted using the miRDB database and confirmed by the luciferase reporter assay. The results of the present study demonstrated that miR‑375‑3p was downregulated in LSCC tissues and cell lines. Furthermore, overexpression of miR‑375‑3p significantly suppressed the proliferation and cell cycle progression of LSCC cells. Overexpression of miR‑375‑3p also increased LSCC cell apoptosis. Mechanistical analysis indicated that miR‑375‑3p bound the 3'‑untranslated region of the hepatocyte nuclear factor 1β (HNF1β) and decreased its expression in LSCC cells. Consistent with the role of HNF1β in glucose metabolism, overexpression of miR‑375‑3p significantly inhibited glucose consumption and lactate production in LSCC cells. Transfection with HNF1β notably reversed the inhibitory effect of miR‑375‑3p on the proliferation of LSCC cells. Collectively, these results indicate the tumor suppressive role of miR‑375‑3p in LSCC via HNF1β, suggesting that miR‑375‑3p may serve as a potential target in the treatment of LSCC.

View Figures

View References

1	Lu ZM, Lin YF, Jiang L, Chen LS, Luo XN, Song XH, Chen SH and Zhang SY: Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma. OncoTargets Ther. 7:525–533. 2014. View Article : Google Scholar
2	Tataru D, Mak V, Simo R, Davies EA and Gallagher JE: Trends in the epidemiology of head and neck cancer in London. Clin Otolaryngol. 42:104–114. 2017. View Article : Google Scholar : PubMed/NCBI
3	Gao C and Hu S: miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma. Cancer Biol Ther. 20:826–836. 2019. View Article : Google Scholar : PubMed/NCBI
4	Marur S and Forastiere AA: Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc. 91:386–396. 2016. View Article : Google Scholar : PubMed/NCBI
5	Palumbo A Jr, De Martino M, Esposito F, Fraggetta F, Neto PN, Valverde Fernandes P, Santos IC, Dias FL, Nasciutti LE, Meireles Da Costa N, et al: HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas. Histopathology. 72:1102–1114. 2018. View Article : Google Scholar : PubMed/NCBI
6	Ozmen OA, Alpay M, Saraydaroglu O, Demir UL, Kasapoglu F, Coskun HH and Basut OI: Prognostic significance of soft tissue deposits in laryngeal carcinoma. Braz J Otorhinolaryngol. 84:566–573. 2018. View Article : Google Scholar : PubMed/NCBI
7	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
8	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
9	Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
10	Mohr AM and Mott JL: Overview of microRNA biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
11	Gentilin E, Degli Uberti E and Zatelli MC: Strategies to use microRNAs as therapeutic targets. Best Pract Res Clin Endocrinol Metab. 30:629–639. 2016. View Article : Google Scholar : PubMed/NCBI
12	Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M and Sahebkar A: Curcumin as a MicroRNA Regulator in Cancer: A Review. Rev Physiol Biochem Pharmacol. 171:1–38. 2016. View Article : Google Scholar : PubMed/NCBI
13	Iorio MV and Croce CM: MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
14	Asadzadeh Z, Mansoori B, Mohammadi A, Aghajani M, Haji-Asgarzadeh K, Safarzadeh E, Mokhtarzadeh A, Duijf PHG and Baradaran B: microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities. J Cell Physiol. 234:10002–10017. 2019. View Article : Google Scholar : PubMed/NCBI
15	Hosseinahli N, Aghapour M, Duijf PHG and Baradaran B: Treating cancer with microRNA replacement therapy: A literature review. J Cell Physiol. 233:5574–5588. 2018. View Article : Google Scholar : PubMed/NCBI
16	Kwak PB, Iwasaki S and Tomari Y: The microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010. View Article : Google Scholar : PubMed/NCBI
17	Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011. View Article : Google Scholar : PubMed/NCBI
18	Li X, Wang HL, Peng X, Zhou HF and Wang X: miR-1297 mediates PTEN expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun. 427:254–260. 2012. View Article : Google Scholar : PubMed/NCBI
19	Yungang W, Xiaoyu L, Pang T, Wenming L and Pan X: miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother. 68:149–154. 2014. View Article : Google Scholar : PubMed/NCBI
20	Luo M, Sun G and Sun JW: miR-196b affects the progression and prognosis of human LSCC through targeting PCDH-17. Auris Nasus Larynx. 46:583–592. 2019. View Article : Google Scholar : PubMed/NCBI
21	Han L, Tang M, Xu X, Jiang B, Wei Y, Qian H and Lu X: miR-143-3p suppresses cell proliferation, migration, and invasion by targeting melanoma-associated antigen A9 in laryngeal squamous cell carcinoma. J Cell Biochem. Oct 9–2018.(Epun ahead of print).
22	Niu JT, Zhang LJ, Huang YW, Li C, Jiang N and Niu YJ: miR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7. Biochem Cell Biol. 96:752–760. 2018. View Article : Google Scholar : PubMed/NCBI
23	Chen X, Zhang L and Tang S: MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2. Auris Nasus Larynx. 46:106–113. 2019. View Article : Google Scholar : PubMed/NCBI
24	Jamali Z, Asl Aminabadi N, Attaran R, Pournagiazar F, Ghertasi Oskouei S and Ahmadpour F: MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: A systematic review and meta-analysis. Oral Oncol. 51:321–331. 2015. View Article : Google Scholar : PubMed/NCBI
25	Zheng J: Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Oncol Lett. 4:1151–1157. 2012. View Article : Google Scholar : PubMed/NCBI
26	Akram M: Mini-review on glycolysis and cancer. J Cancer Educ. 28:454–457. 2013. View Article : Google Scholar : PubMed/NCBI
27	Li XB, Gu JD and Zhou QH: Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy. Thorac Cancer. 6:17–24. 2015. View Article : Google Scholar : PubMed/NCBI
28	Amano Y, Mandai M, Yamaguchi K, Matsumura N, Kharma B, Baba T, Abiko K, Hamanishi J, Yoshioka Y and Konishi I: Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival. Oncotarget. 6:26002–26017. 2015. View Article : Google Scholar : PubMed/NCBI
29	Mandai M, Amano Y, Yamaguchi K, Matsumura N, Baba T and Konishi I: Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction. Oncotarget. 6:30704–30714. 2015. View Article : Google Scholar : PubMed/NCBI
30	Okamoto T, Mandai M, Matsumura N, Yamaguchi K, Kondoh H, Amano Y, Baba T, Hamanishi J, Abiko K, Kosaka K, et al: Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma. Mol Carcinog. 54:35–49. 2015. View Article : Google Scholar : PubMed/NCBI
31	Kato N and Motoyama T: Hepatocyte nuclear factor-1beta (HNF-1beta) in human urogenital organs: Its expression and role in embryogenesis and tumorigenesis. Histol Histopathol. 24:1479–1486. 2009.PubMed/NCBI
32	Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer. 19:471–479. 2009. View Article : Google Scholar : PubMed/NCBI
33	Bockenhauer D and Jaureguiberry G: HNF1B-associated clinical phenotypes: The kidney and beyond. Pediatr Nephrol. 31:707–714. 2016. View Article : Google Scholar : PubMed/NCBI
34	Bártů M, Dundr P, Němejcová K, Tichá I, Hojný H and Hájková N: The Role of HNF1B in Tumorigenesis of Solid Tumours: A Review of Current Knowledge. Folia Biol (Praha). 64:71–83. 2018.PubMed/NCBI
35	Zheng J, Liu X, Xue Y, Gong W, Ma J, Xi Z, Que Z and Liu Y: TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway. J Hematol Oncol. 10:522017. View Article : Google Scholar : PubMed/NCBI
36	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
37	Edge SB and Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surgl Oncol. 17:1471–1474. 2010. View Article : Google Scholar
38	Voigt JJ: Recommendations of the FNCLCC Sarcoma Group for pathologic management of soft tissue sarcoma in adults. Ann Pathol. 19:1531999.(In French). PubMed/NCBI
39	Shen Z, Yuan J, Tong Q, Hao W, Deng H, Li Q, Zhou C, Hu Y and Xu J: Long non-coding RNA AC023794.4-201 exerts a tumor-suppressive function in laryngeal squamous cell cancer and may serve as a potential prognostic biomarker. Oncol Lett. 20:774–784. 2020.PubMed/NCBI
40	Fan Y, Xia X, Zhu Y, Diao W, Zhu X, Gao Z and Chen X: Circular RNA expression profile in laryngeal squamous cell carcinoma revealed by microarray. Cell Physiol Biochem. 50:342–352. 2018. View Article : Google Scholar : PubMed/NCBI
41	Yu CH, Xing FY, Zhang JY, Xu JQ and Li YC: A combination of mRNA expression profile and miRNA expression profile identifies detection biomarkers in different tumor stages of laryngeal squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 22:7296–7304. 2018.PubMed/NCBI
42	Zhang F and Cao H: MicroRNA-143-3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k-Ras/Raf/MEK/ERK signaling pathway. Int J Oncol. 54:689–701. 2019.PubMed/NCBI
43	Kaboli PJ, Rahmat A, Ismail P and Ling KH: MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacol Res. 97:104–121. 2015. View Article : Google Scholar : PubMed/NCBI